Enanta Pharmaceuticals In...

NASDAQ: ENTA · Real-Time Price · USD
7.71
-0.03 (-0.39%)
At close: Aug 15, 2025, 2:36 PM

Enanta Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Net Income
-116.05M -133.82M -121.75M -79M
Depreciation & Amortization
2.34M 2.37M 2.97M 3.33M
Stock-Based Compensation
26.8M 28.22M 26.97M 20.99M
Other Working Capital
6.57M -243K -372K 6.84M
Other Non-Cash Items
1.02M 2.6M 242K -1.98M
Deferred Income Tax
n/a -10.55M n/a 345K
Change in Working Capital
7.13M 8.02M 6.79M -13.69M
Operating Cash Flow
-78.76M -103.15M -84.78M -70M
Capital Expenditures
-17.95M -9.06M -2.13M -750K
Cash Acquisitions
n/a 44.52M -54.9M -37.74M
Purchase of Investments
-307.28M -373.39M -171.45M -307.35M
Sales Maturities Of Investments
383.46M 328.87M 228.47M 345.09M
Other Investing Acitivies
n/a -44.52M 54.9M 37.74M
Investing Cash Flow
58.23M -53.58M 54.9M 36.99M
Debt Repayment
-27.48M 199.68M n/a n/a
Common Stock Repurchased
n/a n/a -1.23M -534K
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-294K -3.76M -1.23M -534K
Financial Cash Flow
-27.63M 198.13M 20.03M 3.08M
Net Cash Flow
-48.16M 41.39M -9.85M -29.93M
Free Cash Flow
-96.71M -112.21M -86.91M -70.75M